about
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanismsAdaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations.Target Identification in Small Cell Lung Cancer via Integrated Phenotypic Screening and Activity-Based Protein ProfilingActivity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung Cancer.Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer.Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.HDAC6 deficiency induces apoptosis in mesenchymal stem cells through p53 K120 acetylation.
P50
Q24339394-C68DBDEE-01FE-4F1A-A411-20C54C70EADEQ35077627-6A0451A3-7B22-4E8C-BF86-69D59F2017A9Q35895426-4EF1DF4B-B0D6-4D6B-AC11-36F83F00B4AFQ37566368-04F4269C-2DCA-462A-AB28-14A55CA7AEF2Q38757884-20FDDD76-4EE0-499A-B855-2F4CA87EFD2CQ41661254-445009A2-67E0-4BAF-83A2-147B8308551BQ46279059-3C4277F6-B552-4CC5-8121-298575829931
P50
description
researcher ORCID ID = 0000-0001-6700-1372
@en
name
Jae-Young Kim
@ast
Jae-Young Kim
@en
Jae-Young Kim
@es
Jae-Young Kim
@nl
type
label
Jae-Young Kim
@ast
Jae-Young Kim
@en
Jae-Young Kim
@es
Jae-Young Kim
@nl
prefLabel
Jae-Young Kim
@ast
Jae-Young Kim
@en
Jae-Young Kim
@es
Jae-Young Kim
@nl
P1153
57195475150
P31
P496
0000-0001-6700-1372